$1.49 Billion is the total value of QVT Financial LP's 63 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VVUS | New | VIVUS INC | $105,001,000 | – | 8,346,697 | +100.0% | 7.06% | – |
| New | SALESFORCE COM INCnote 0.750% 1/1 | $95,303,000 | – | 52,500,000 | +100.0% | 6.41% | – | |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $86,889,000 | – | 10,967,853 | +100.0% | 5.84% | – |
| THC | New | TENET HEALTHCARE CORP | $76,733,000 | – | 1,664,493 | +100.0% | 5.16% | – |
| New | ILLUMINA INCnote 0.625% 2/1 | $55,319,000 | – | 16,135,000 | +100.0% | 3.72% | – | |
| COF | New | CAPITAL ONE FINL CORP | $48,881,000 | – | 778,235 | +100.0% | 3.29% | – |
| ETFC | New | E TRADE FINANCIAL CORP | $47,646,000 | – | 3,763,493 | +100.0% | 3.20% | – |
| New | WESCO INTL INCdbcv 6.000% 9/1 | $47,053,000 | – | 19,000,000 | +100.0% | 3.16% | – | |
| New | SBA COMMUNICATIONS CORPnote 4.000%10/0 | $43,219,000 | – | 17,500,000 | +100.0% | 2.91% | – | |
| CLVS | New | CLOVIS ONCOLOGY INC | $41,372,000 | – | 617,678 | +100.0% | 2.78% | – |
| PCYC | New | PHARMACYCLICS INC | $41,323,000 | – | 519,982 | +100.0% | 2.78% | – |
| CREE | New | CREE INCput | $38,298,000 | – | 600,000 | +100.0% | 2.58% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $36,582,000 | – | 4,601,500 | +100.0% | 2.46% | – |
| STNG | New | SCORPIO TANKERS INC | $33,927,000 | – | 3,778,084 | +100.0% | 2.28% | – |
| RDC | New | ROWAN COMPANIES PLC | $33,251,000 | – | 975,954 | +100.0% | 2.24% | – |
| JPM | New | JPMORGAN CHASE & CO | $32,807,000 | – | 621,460 | +100.0% | 2.21% | – |
| DST | New | DST SYS INC DEL | $30,952,000 | – | 473,783 | +100.0% | 2.08% | – |
| GDOT | New | GREEN DOT CORPcl a | $29,809,000 | – | 1,494,181 | +100.0% | 2.00% | – |
| ITMN | New | INTERMUNE INC | $27,531,000 | – | 2,861,868 | +100.0% | 1.85% | – |
| MDVN | New | MEDIVATION INC | $26,943,000 | – | 547,628 | +100.0% | 1.81% | – |
| LM | New | LEGG MASON INC | $26,116,000 | – | 842,168 | +100.0% | 1.76% | – |
| New | NATIONAL RETAIL PPTYS INCnote 5.125% 6/1 | $25,867,000 | – | 19,000,000 | +100.0% | 1.74% | – | |
| New | MEDIVATION INCnote 2.625% 4/0 | $25,242,000 | – | 19,750,000 | +100.0% | 1.70% | – | |
| YPF | New | YPF SOCIEDAD ANONIMAspon adr cl d | $25,188,000 | – | 1,706,509 | +100.0% | 1.69% | – |
| OCN | New | OCWEN FINL CORPput | $25,152,000 | – | 610,200 | +100.0% | 1.69% | – |
| TSLA | New | TESLA MTRS INC | $24,156,000 | – | 225,000 | +100.0% | 1.62% | – |
| RIG | New | TRANSOCEAN LTD | $23,800,000 | – | 496,343 | +100.0% | 1.60% | – |
| OPTR | New | OPTIMER PHARMACEUTICALS INC | $23,583,000 | – | 1,629,800 | +100.0% | 1.59% | – |
| RPRX | New | REPROS THERAPEUTICS INC | $22,091,000 | – | 1,240,588 | +100.0% | 1.49% | – |
| C | New | CITIGROUP INC | $22,060,000 | – | 459,873 | +100.0% | 1.48% | – |
| BRFS | New | BRF SAsponsored adr | $21,650,000 | – | 997,220 | +100.0% | 1.46% | – |
| INFI | New | INFINITY PHARMACEUTICALS INC | $21,480,000 | – | 1,326,610 | +100.0% | 1.44% | – |
| CBRE | New | CBRE GROUP INCcl a | $19,420,000 | – | 831,320 | +100.0% | 1.31% | – |
| New | INTERMUNE INCnote 2.500%12/1 | $19,331,000 | – | 18,000,000 | +100.0% | 1.30% | – | |
| WFC | New | WELLS FARGO & CO NEW | $17,304,000 | – | 419,292 | +100.0% | 1.16% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $15,605,000 | – | 3,437,293 | +100.0% | 1.05% | – |
| RPRXW | New | REPROS THERAPEUTICS INC*w exp 02/08/201 | $15,566,000 | – | 874,635 | +100.0% | 1.05% | – |
| HCA | New | HCA HOLDINGS INC | $14,681,000 | – | 407,118 | +100.0% | 0.99% | – |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $12,131,000 | – | 2,430,985 | +100.0% | 0.82% | – |
| RPRXZ | New | REPROS THERAPEUTICS INC*w exp 02/08/201 | $10,859,000 | – | 708,969 | +100.0% | 0.73% | – |
| CST | New | CST BRANDS INC | $9,320,000 | – | 302,500 | +100.0% | 0.63% | – |
| PSMI | New | PEREGRINE SEMICONDUCTOR CORP | $8,728,000 | – | 800,000 | +100.0% | 0.59% | – |
| New | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $8,563,000 | – | 9,000,000 | +100.0% | 0.58% | – | |
| OLED | New | UNIVERSAL DISPLAY CORPput | $8,433,000 | – | 300,000 | +100.0% | 0.57% | – |
| ANAC | New | ANACOR PHARMACEUTICALS INC | $7,593,000 | – | 1,358,303 | +100.0% | 0.51% | – |
| ZXAIY | New | CHINA ZENIX AUTO INTL LTDads | $7,070,000 | – | 3,047,200 | +100.0% | 0.48% | – |
| KERX | New | KERYX BIOPHARMACEUTICALS INC | $6,813,000 | – | 912,000 | +100.0% | 0.46% | – |
| STML | New | STEMLINE THERAPEUTICS INC | $5,245,000 | – | 220,000 | +100.0% | 0.35% | – |
| New | CMS ENERGY CORPnote 5.500% 6/1 | $4,978,000 | – | 2,500,000 | +100.0% | 0.34% | – | |
| OGXI | New | ONCOGENEX PHARMACEUTICALS IN | $3,920,000 | – | 400,000 | +100.0% | 0.26% | – |
| EPZM | New | EPIZYME INC | $3,516,000 | – | 125,000 | +100.0% | 0.24% | – |
| VSTM | New | VERASTEM INC | $3,397,000 | – | 271,101 | +100.0% | 0.23% | – |
| PACD | New | PACIFIC DRILLING SA LUXEMBOU | $3,226,000 | – | 329,815 | +100.0% | 0.22% | – |
| ABG | New | ASBURY AUTOMOTIVE GROUP INC | $2,810,000 | – | 70,074 | +100.0% | 0.19% | – |
| QLTI | New | QLT INC | $2,744,000 | – | 625,000 | +100.0% | 0.18% | – |
| DYAX | New | DYAX CORP | $2,667,000 | – | 770,683 | +100.0% | 0.18% | – |
| NCTY | New | THE9 LTDadr | $2,454,000 | – | 752,963 | +100.0% | 0.16% | – |
| PTN | New | PALATIN TECHNOLOGIES INC | $2,050,000 | – | 3,873,000 | +100.0% | 0.14% | – |
| HLSSF | New | HOME LN SERVICING SOLUTIONSput | $1,867,000 | – | 77,900 | +100.0% | 0.13% | – |
| TZYM | New | TRANZYME INC | $538,000 | – | 1,145,655 | +100.0% | 0.04% | – |
| WLTGQ | New | WALTER ENERGY INC | $513,000 | – | 49,300 | +100.0% | 0.04% | – |
| IDIX | New | IDENIX PHARMACEUTICALS INC | $361,000 | – | 100,000 | +100.0% | 0.02% | – |
| ARRWS | New | ARMOUR RESIDENTIAL REIT INC*w exp 11/07/201 | $0 | – | 1,651,796 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
| 13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.